Related Experiment Video
Updated: Aug 24, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.9K
Noncoding RNAs and Virus and Treatment in Allergic Rhinitis
Zhu Lei1, Guangrui Feng2, Zhiguo Wang3
1Otolaryngology Department, Xianning First People's Hospital, Xianning 437100, Hubei, China.
Evidence-Based Complementary and Alternative Medicine : Ecam
|October 26, 2022
Summary
This review explores how noncoding RNAs (ncRNAs) interact with viral infections to influence allergic rhinitis (AR). It summarizes current understanding and treatments targeting ncRNAs in AR development over the last five years.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Allergic rhinitis (AR) is an IgE-mediated hypersensitivity.
- Noncoding RNAs (ncRNAs), including miRNAs and lncRNAs, regulate gene expression and immune function.
- Viral infections like RSV and hMPV can worsen AR, but mechanisms are unclear.
Purpose of the Study:
- To review the complex interactions between ncRNAs and viral infections in AR.
- To summarize recent (5-year) therapeutic strategies targeting ncRNAs for AR.
Main Methods:
- Literature review of studies on ncRNAs, viral infections, and allergic rhinitis.
- Analysis of mechanisms linking ncRNAs, viruses, and immune responses in AR.
- Synthesis of current treatment approaches focusing on ncRNAs in AR.
Main Results:
- ncRNAs play a significant role in the interplay between viral infections and AR.
- Specific ncRNAs are implicated in modulating immune responses during co-infections.
- Emerging treatments focus on modulating ncRNA activity for AR management.
Conclusions:
- Understanding ncRNA-virus interactions is crucial for AR pathogenesis.
- Targeting ncRNAs offers potential therapeutic avenues for AR.
- Further research is needed to elucidate precise mechanisms and optimize treatments.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
344
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
344
01:29Viruses with RNA Genomes
90
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
90
02:30siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
01:23Types of RNA
64.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
552
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
552
02:39lncRNA - Long Non-coding RNAs
8.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K